Table 3.
Metabolite | Placebo_T1 | Placebo_T2 | p-Value |
---|---|---|---|
Cholesteryl Esters | |||
CE(14:0) | 35.4 (±12.9) | 30.4 (±12.7) | 0.016 |
CE(14:1) | 1.1 (±0.9) | 0.9 (±0.8) | 0.192 |
CE(15:0) | 14.8 (±5.4) | 12.5 (±4.8) | 0.009 |
CE(15:1) | 0.8 (±0.2) | 0.7 (±0.3) | 0.134 |
CE(16:0) | 270.5 (±51.4) | 242.8 (±50.7) | <0.001 |
CE(16:1) | 95.9 (±42.3) | 82.5 (±38.1) | 0.001 |
CE(17:0) | 10.5 (±3.9) | 9.2 (±3) | 0.004 |
CE(17:1) | 8 (±3.5) | 7 (±3.1) | 0.032 |
CE(18:0) | 22.1 (±6.3) | 20.2 (±6.8) | 0.001 |
CE(18:1) | 540.3 (±150) | 491.7 (±149.8) | 0.007 |
CE(18:2) | 1597 (±322.4) | 1468.9 (±313.1) | <0.001 |
CE(18:3) | 96 (±36.2) | 82.3 (±36.9) | <0.001 |
CE(20:0) | 2 (±0.6) | 1.5 (±0.5) | 0.007 |
CE(20:1) | 0.8 (±0.2) | 0.7 (±0.3) | 0.211 |
CE(20:3) | 37.8 (±15.6) | 32.7 (±12.8) | 0.006 |
CE(20:4) | 318.3 (±112.7) | 288.1 (±105) | 0.001 |
CE(20:5) | 131.1 (±64.4) | 99 (±51.1) | <0.001 |
CE(22:2) | 0.2 (±0.1) | 0.1 (±0) | 0.184 |
CE(22:5) | 3.1 (±1) | 2.9 (±1) | 0.08 |
CE(22:6) | 51.5 (±20.8) | 44.6 (±15.9) | 0.003 |
Bile Acids | |||
Cholic acid | 0.3 (±0.3) | 0.3 (±0.2) | 0.61 |
Deoxycholic acid | 0.2 (±0.2) | 0.3 (±0.2) | 0.027 |
Glycocholic acid | 0.1 (±0.2) | 0.2 (±0.1) | 0.059 |
Glycochenodeoxycholic acid | 0.3 (±0.3) | 0.4 (±0.3) | 0.023 |
Glycodeoxycholic acid | 0.1 (±0.2) | 0.2 (±0.2) | 0.111 |
Glycolithocholic acid | 0.01 (±0) | 0.01 (±0) | 0.707 |
Glycolithocholic acid sulfate | 0.2 (±0.2) | 0.2 (±0.2) | 0.312 |
Glycoursodeoxycholic acid | 0.01 (+0) | 0.1 (±0) | <0.001 |
Taurocholic acid | 0.01 (±0) | 0.01 (±0) | 0.242 |
Taurochenodeoxycholic acid | 0.01 (±0) | 0.1 (±0.1) | 0.158 |
Taurodeoxycholic acid | 0.01 (±0) | 0.01 (±0.1) | 0.469 |
Data are presented as mean (µmol/L) ± standard error of mean (SEM).